Burjeel marks September childhood cancer month with family care push in Abu Dhabi

Burjeel Cancer Institute at Burjeel Medical City in Abu Dhabi marked Childhood Cancer Awareness Month with a family-centred event on 26 September 2026, bringing together children in treatment, survivors and families, according to Emirates News Agency (WAM).

For UAE operators, the useful signal is operational rather than ceremonial. Paediatric oncology is a long-cycle service line. It needs licensed oncology capacity, family counselling, school and work coordination, insurer pre-authorisation, and reliable referral routes between Dubai, Abu Dhabi and the northern emirates. In Dubai, the Dubai Health Authority (DHA) issued its Standards of Oncology Services circular on 3 April 2024. In Abu Dhabi and Al Ain, the relevant regulator is the Department of Health Abu Dhabi (DOH). In Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah and Fujairah, operators should check Ministry of Health and Prevention (MOHAP) requirements.

Why Dubai clinics should pay attention

Dubai clinics that see children with persistent symptoms, abnormal blood counts or suspected solid tumours need a written referral path to a licensed paediatric oncology provider. The business issue is leakage and delay. If a clinic cannot explain where the child goes next, the family will search across emirates, insurers and hospital brands on its own.

DHA’s 2024 oncology standards apply to health facilities under DHA jurisdiction that provide oncology services. They give Dubai operators a compliance anchor for service scope, clinical governance and referral decisions. A clinic that does not provide oncology should still maintain a referral protocol, named receiving facilities, records-transfer steps and a parent communication script. That is a COO issue, not a marketing exercise.

• Check whether the child’s plan covers oncology consultations, diagnostic imaging, pathology, chemotherapy day care and inpatient admission before referral.
• Ask the receiving provider for an itemised estimate by service code, because paediatric cancer pricing varies by diagnosis, drug regimen, length of stay and network status.
• Record the payer route for Daman, Thiqa or Sukoon members where relevant, including pre-authorisation documents and expected response time.
• Confirm whether family counselling, nutrition, rehabilitation and psychology are covered benefits or self-pay add-ons.

Abu Dhabi service lines are competing on support

Burjeel’s event was held under the theme Hope Begins with Family and linked to the UAE’s Year of Family. WAM said children and families took part in creative and entertainment activities with medical and administrative teams. The report also cited the case of Saif, an Emirati child diagnosed with a kidney tumour, as an example of diagnosis, treatment and ongoing family support.

“Hope Begins with Family” — Burjeel Cancer Institute event theme, reported by Emirates News Agency on 26 September 2026.

The commercial point is that paediatric oncology providers are now making family support part of the service proposition. That matters for chief medical officers, insurers and marketing heads. Families judge cancer care through appointment access, clarity of treatment plans, accommodation for siblings, school disruption and financial navigation. Clinical quality remains the base requirement. The visible difference is often the non-clinical workflow.

BCI’s own service pages describe paediatric haematology, paediatric surgical oncology and paediatric radiation oncology, including family-centred care and treatment planning. Operators should avoid copying the label without the staffing model. Family-centred oncology requires named owners for counselling, consent, translation, case coordination and insurer documentation. A poster campaign does not solve those tasks.

What insurers and patients should ask next

For insurers, childhood cancer pathways are high-cost and time-sensitive. A single case can involve diagnostics, central line placement, surgery, chemotherapy, radiation, infection admissions and long follow-up. The practical payer question is whether the network has enough paediatric oncology capacity inside the UAE, and whether approvals are fast enough for treatment decisions made over days rather than weeks.

For patients and employers, price discovery should happen before the first treatment cycle where clinically possible. Families should ask providers for a written estimate that separates consultation, imaging, laboratory tests, drugs, day-care administration, inpatient charges and supportive services. If the provider cannot give a final figure before staging is complete, it should state which items are still unknown and when they will be priced.

Dubai operators should start with DHA-licensed providers and DHA oncology standards. Abu Dhabi and Al Ain operators should check DOH licensing and facility scope. Northern emirates clinics should use MOHAP channels and referral links to licensed oncology centres. Patients comparing options can start with the UAE Open Healthcare Directory, which lists licensed healthcare providers across all seven emirates and can be filtered for oncology providers, locations, ratings, insurance plans and contact details.